Virtus ETF Advisers LLC Rhythm Pharmaceuticals, Inc. Transaction History

Virtus ETF Advisers LLC

$196 Million
Q2 2024

A detailed history of Virtus ETF Advisers LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 7,423 shares of RYTM stock, worth $364,098. This represents 0.15% of its overall portfolio holdings.

Number of Shares

7,423

Previous 8,874 16.35%

Holding current value

$364,098

Previous $384,000 20.83%

% of portfolio

0.15%

Previous 0.21%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$35.41 - $44.37 $51,379 - $64,380	-1,451 Reduced 16.35%	7,423 $304,000
Q1 2024 May 15, 2024	BUY	$39.12 - $52.44 $49,956 - $66,965	1,277 Added 16.81%	8,874 $384,000
Q4 2023 Feb 15, 2024	SELL	$21.39 - $49.64 $205,258 - $476,345	-9,596 Reduced 55.81%	7,597 $349,000
Q3 2023 Nov 07, 2023	SELL	$15.81 - $27.8 $35,114 - $61,743	-2,221 Reduced 11.44%	17,193 $394,000
Q2 2023 Aug 14, 2023	BUY	$16.32 - $21.15 $147,043 - $190,561	9,010 Added 86.6%	19,414 $320,000
Q1 2023 May 15, 2023	BUY	$16.88 - $34.24 $3,089 - $6,265	183 Added 1.79%	10,404 $185,000
Q4 2022 Feb 14, 2023	BUY	$22.21 - $30.25 $227,008 - $309,185	10,221 New	10,221 $297,000
Q2 2022 Aug 12, 2022	SELL	$3.12 - $12.25 $50,909 - $199,883	-16,317 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.13 - $12.24 $5,964 - $11,909	-973 Reduced 5.63%	16,317 $188,000
Q4 2021 Feb 14, 2022	BUY	$8.62 - $13.9 $60,865 - $98,147	7,061 Added 69.03%	17,290 $173,000
Q3 2021 Nov 15, 2021	SELL	$11.68 - $20.72 $6,260 - $11,105	-536 Reduced 4.98%	10,229 $134,000
Q2 2021 Aug 10, 2021	BUY	$18.52 - $22.55 $15,297 - $18,626	826 Added 8.31%	10,765 $211,000
Q1 2021 May 17, 2021	BUY	$20.25 - $39.49 $3,381 - $6,594	167 Added 1.71%	9,939 $211,000
Q4 2020 Feb 12, 2021	SELL	$21.17 - $32.61 $118,806 - $183,007	-5,612 Reduced 36.48%	9,772 $291,000
Q3 2020 Nov 13, 2020	SELL	$18.13 - $30.61 $38,073 - $64,281	-2,100 Reduced 12.01%	15,384 $333,000
Q2 2020 Aug 05, 2020	BUY	$14.41 - $25.35 $32,566 - $57,291	2,260 Added 14.84%	17,484 $390,000
Q1 2020 May 14, 2020	SELL	$13.16 - $22.9 $29,294 - $50,975	-2,226 Reduced 12.76%	15,224 $232,000
Q4 2019 Feb 13, 2020	BUY	$19.53 - $25.5 $119,953 - $156,621	6,142 Added 54.32%	17,450 $401,000
Q3 2019 Nov 12, 2019	SELL	$18.62 - $24.51 $11,730 - $15,441	-630 Reduced 5.28%	11,308 $244,000
Q2 2019 Aug 13, 2019	BUY	$21.11 - $28.48 $52,141 - $70,345	2,470 Added 26.09%	11,938 $263,000
Q1 2019 May 14, 2019	SELL	$24.76 - $31.66 $25,849 - $33,053	-1,044 Reduced 9.93%	9,468 $260,000
Q4 2018 Feb 05, 2019	SELL	$24.11 - $31.34 $85,156 - $110,692	-3,532 Reduced 25.15%	10,512 $283,000
Q3 2018 Nov 14, 2018	SELL	$26.99 - $35.85 $278,806 - $370,330	-10,330 Reduced 42.38%	14,044 $410,000
Q2 2018 Aug 10, 2018	BUY	$17.02 - $35.2 $414,845 - $857,964	24,374 New	24,374 $762,000

Others Institutions Holding RYTM

# of Institutions

177

Shares Held

68.5M

Call Options Held

467K

Put Options Held

224K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $2.73B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Rhythm Pharmaceuticals, Inc. Transaction History